logo

CGEM

CullinanยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

CGEM Profile

Cullinan Therapeutics, Inc.

A biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for patients with cancer

Pharmaceutical
--
01/08/2021
NASDAQ Stock Exchange
111
12-31
Common stock
One Main Street, Suite 520, Cambridge, MA 02142
--
Cullinan Therapeutics, Inc., is incorporated in Delaware. The company is a biopharmaceutical company focused on developing a diverse pipeline of tumor-targeted therapies and immuno-oncology therapies with translational potential for cancer patients.